Comment on:: !Nauck MA, !Duran S, !Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin:: a non-inferiority study.: Diabetologia 50:259-267

被引：10

作者：

Home, P. D. ^{[1
]}

机构：

[1] Univ Newcastle Upon Tyne, Sch Med, SCMS Diabet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England

来源：

DIABETOLOGIA | 2007年 / 50卷 / 07期

关键词：

D O I：

10.1007/s00125-007-0653-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1561 / 1562

页数：2

共 8 条

[1] Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes [J].

DeFronzo, RA ;

Ratner, RE ;

Han, J ;

Kim, DD ;

Fineman, MS ;

Baron, AD .

DIABETES CARE, 2005, 28 (05) :1092-1100

[2] Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study) [J].

Garber, AJ ;

Wahlen, J ;

Wahl, T ;

Bressler, P ;

Braceras, R ;

Allen, E ;

Jain, R .

DIABETES OBESITY & METABOLISM, 2006, 8 (01) :58-66

[3]

Heine RJ, 2005, ANN INTERN MED, V143, P559, DOI 10.7326/0003-4819-143-8-200510180-00006

[4] A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes [J].

Hermansen, Kjeld ;

Davies, Melanie ;

Derezinski, Taudeusz ;

Ravn, Gabrielle Martinez ;

Clauson, Per ;

Home, Philip .

DIABETES CARE, 2006, 29 (06) :1269-1274

[5] A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study [J].

Nauck, M. A. ;

Duran, S. ;

Kim, D. ;

Johns, D. ;

Northrup, J. ;

Festa, A. ;

Brodows, R. ;

Trautmann, M. .

DIABETOLOGIA, 2007, 50 (02) :259-267

[6] Initiating insulin therapy in type 2 diabetes - A comparison of biphasic and basal insulin analogs [J].

Raskin, P ;

Hu, P ;

Allen, E ;

Bode, B ;

Hollander, P ;

Garber, A ;

Lewin, A ;

Gabbay, RA .

DIABETES CARE, 2005, 28 (02) :260-265

[7] The treat-to-target trial - Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients [J].

Riddle, MC ;

Rosenstock, J ;

Gerich, J .

DIABETES CARE, 2003, 26 (11) :3080-3086

[8] Insulin glargine or NPH combined with metformin in type 2 diabetes:: the LANMET study [J].

Yki-Järvinen, H ;

Kauppinen-Mäkelin, R ;

Tiikkainen, M ;

Vähätalo, M ;

Virtamo, H ;

Nikkilä, K ;

Tulokas, T ;

Hulme, S ;

Hardy, K ;

McNulty, S ;

Hänninen, J ;

Levänen, H ;

Lahdenperä, S ;

Lehtonen, R ;

Ryysy, L .

DIABETOLOGIA, 2006, 49 (03) :442-451

← 1 →